Pegylated Interferon a 2a plus Tenofovir or Placebo forthe treatment of hepatitis delta First results of the HIDIT 2 study

YURTAYDIN S. C., Wedemeyer H., Caruntu F. A., Curescu M. G., YALÇIN K., AKARCA U. S., ...More

AASLD 2012 63rd Annual Meeting of the American Association for the Study of Liver Disease, 9 - 13 November 2012

  • Publication Type: Conference Paper / Full Text
  • Hacettepe University Affiliated: No